Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-048385
Filing Date
2023-04-21
Accepted
2023-04-21 16:08:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm231857d4_defa14a.htm DEFA14A 12304
2 GRAPHIC tm231857d4_defa14aimg001.jpg GRAPHIC 347918
3 GRAPHIC tm231857d4_defa14aimg002.jpg GRAPHIC 234130
  Complete submission text file 0001104659-23-048385.txt   815538
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35060 | Film No.: 23836435
SIC: 2834 Pharmaceutical Preparations